Ana Laus to Phosphatidylinositol 3-Kinases
This is a "connection" page, showing publications Ana Laus has written about Phosphatidylinositol 3-Kinases.
Connection Strength
0.046
-
da Silva-Oliveira RJ, Gomes INF, da Silva LS, Lengert AVH, Laus AC, Melendez ME, Munari CC, Cury FP, Longato GB, Reis RM. Efficacy of Combined Use of Everolimus and Second-Generation Pan-EGRF Inhibitors in KRAS Mutant Non-Small Cell Lung Cancer Cell Lines. Int J Mol Sci. 2022 Jul 14; 23(14).
Score: 0.046